Cart (0 Items)
Your cart is currently empty.
View Products
How can CAR-T cell engineering overcome the remaining limitations of cell therapy? CAR-T cell engineering has become one of the most active areas of cancer immunotherapy research.
CAR-T cell therapy is an emerging alternative to conventional anticancer treatments. Over the years, these modified cells have demonstrated promising… Read More
CAR-T cells are a form of adoptive T cell therapy (ACT). This emerging technology combines the cytotoxic potential of T… Read More
Manufacturing CAR-T cells is a complex process requiring the collection of T cells from autologous or allogeneic sources and subsequent… Read More
Prompted by encouraging clinical and preclinical results, the structure of CAR-T cells has evolved rapidly to minimize off-target toxicity and… Read More